Target Name: ZNF549
NCBI ID: G256051
Review Report on ZNF549 Target / Biomarker Content of Review Report on ZNF549 Target / Biomarker
ZNF549
Other Name(s): Zinc finger protein 549 isoform 2 | Zinc finger protein 549, transcript variant 1 | FLJ34917 | Zinc finger protein 549, transcript variant 2 | ZN549_HUMAN | ZNF549 variant 1 | Zinc finger protein 549 (isoform 1) | ZNF549 variant 2 | Zinc finger protein 549 | zinc finger protein 549

ZNF549: A Potential Drug Target and Biomarker

Introduction

Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. ZNF549 is a ZFPs isoform 2 that has been identified as a potential drug target and biomarker. In this article, we will explore the structure, function, and potential clinical applications of ZNF549.

Structure

ZNF549 is a 21-kDa protein that consists of a unique N-terminal ZNF5 domain, a central 尾-sheet, and a C-terminal T-loop domain. The ZNF5 domain is a conserved region that is found in various proteins, including ZNF1 , ZNF2, and ZNF3. The ZNF5 domain is responsible for the protein's unique structure and function.

Function

ZNF549 is involved in various cellular processes, including cell adhesion, migration, and invasion. It plays a critical role in the regulation of cell-cell adhesion by interacting with the cadher protein complex. This interaction helps to maintain the integrity of the plasma membrane and ensures the proper functioning of various cellular processes.

In addition to its role in cell-cell adhesion, ZNF549 has also been shown to be involved in the regulation of cell migration and invasion. It has been shown to play a negative role in the migration of cancer cells and to promote the invasion of cancer cells into the surrounding tissue.

Potential Clinical Applications

The potential clinical applications of ZNF549 are vast. As a drug target, ZNF549 could be used to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In cancer, ZNF549 has been shown to be involved in the regulation of cell growth, survival, and angiogenesis. It has been shown to inhibit the growth of various cancer cell lines and to promote the apoptosis of cancer cells. This suggests that ZNF549 could be an effective anti-cancer drug.

In neurodegenerative diseases, ZNF549 has been shown to be involved in the regulation of neurotransmitter synthesis and release, as well as the regulation of cellular stress. It has been shown to protect against neurotoxicity and to improve the survival of neurodegenerative disease models.

In autoimmune diseases, ZNF549 has been shown to be involved in the regulation of immune cell function and inflammation. It has been shown to protect against the development of autoimmune diseases and to improve the function of autoimmune disease models.

Conclusion

In conclusion, ZNF549 is a unique and highly conserved protein that has the potential to be a drug target and biomarker. Its structure and function have been extensively studied, and its potential clinical applications are vast. Further research is needed to fully understand the role of ZNF549 in various cellular processes and to develop effective treatments for diseases associated with its dysfunction.

Protein Name: Zinc Finger Protein 549

Functions: May be involved in transcriptional regulation

The "ZNF549 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF549 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610 | ZNF611 | ZNF613 | ZNF614 | ZNF615 | ZNF616 | ZNF618 | ZNF619 | ZNF620 | ZNF621 | ZNF622 | ZNF623 | ZNF624 | ZNF625 | ZNF625-ZNF20 | ZNF626 | ZNF627 | ZNF628 | ZNF629 | ZNF630 | ZNF638 | ZNF639 | ZNF641 | ZNF644 | ZNF646 | ZNF648 | ZNF649 | ZNF652 | ZNF652-AS1 | ZNF653 | ZNF654 | ZNF655 | ZNF658 | ZNF658B | ZNF66 | ZNF660 | ZNF662 | ZNF663P